e.l.f. Beauty Earnings Call Balances Growth And Caution

e.l.f. Beauty, Inc. ((ELF)) has held its Q4 earnings call. Read on for the main highlights of the call.

e.l.f. Beauty’s latest earnings call struck a cautiously upbeat tone, balancing robust portfolio-driven growth and strong cash generation with a clear acknowledgment of emerging headwinds. Management emphasized the success of recent acquisitions, rapid international and skincare expansion, and solid margins, while openly flagging softer core brand trends, unit pressure after price hikes, and more measured guidance for fiscal 2027.

Sustained Top-Line Growth

Fiscal 2026 underscored e.l.f. Beauty’s growth credentials, with net sales rising 25% year over year and Q4 sales up 35%. The company notched its 29th straight quarter of net sales growth and seventh consecutive year of industry-leading performance, reinforcing its status as one of the fastest-growing names in beauty.

Portfolio Strength and Market Share Gains

Core e.l.f. Cosmetics posted about $1.8 billion in global retail sales and added 115 basis points of U.S. market share, the largest gain among roughly 1,000 Nielsen-tracked cosmetics brands. Over seven years, the brand has accumulated 29 basis points of share gain and now commands a 13% national share in mass color cosmetics, rising to 21% at Target.

Acquisitions Fuel Diversification

Rhode has quickly become a growth engine, generating over $500 million in annualized global retail sales and roughly $390 million in net sales, with more than 80% year-over-year growth. Naturium nearly doubled pre-acquisition sales to about $250 million in retail sales, helping lift non-e.l.f. brands from zero to around 30% of global consumption in just three years.

Skincare Momentum Builds

Skincare is emerging as a second pillar, with its mix rising from 9% to 23% of global consumption across the portfolio. e.l.f. SKIN reached roughly $200 million in global retail sales and climbed from number 25 to number 11 in U.S. mask care over five years, while Rhode and Naturium rank among the fastest-growing skincare brands in the market.

Profitability and Margins Hold Up

For fiscal 2026, adjusted EBITDA increased 13% and the company delivered a healthy 20% adjusted EBITDA margin despite heavier investments. Q4 gross margin reached 73%, about 140 basis points higher than a year earlier, signaling strong pricing power and mix even as costs and tariffs remained elevated.

International Expansion Accelerates

International net sales rose 38% for the year and an impressive 75% in Q4, underscoring broad-based demand beyond the U.S. The company launched with eight new retail partners across 14 countries and is preparing a September rollout of Rhode at Sephora in Europe, spanning 19 countries and widening its global footprint.

Supply Chain Diversification Reduces Risk

Management highlighted meaningful progress in derisking production, with manufacturing outside China jumping from about 1% to more than 45% of volume over three years. This broader geographic footprint should lessen exposure to country-specific tariffs, logistics disruptions, and political risk as the company scales.

Balance Sheet Strength and Capital Returns

The company ended the year with $290 million in cash, up from $149 million, while keeping net debt below two times adjusted EBITDA. e.l.f. repurchased roughly $50 million of stock and still has about $400 million remaining under its $500 million authorization, providing flexibility for continued buybacks or strategic investments.

Core Brand Consumption Moderation

Beneath the strong headline numbers, core e.l.f. brand consumption slowed from high single-digit growth in fiscal 2026 to low single digits over the most recent 12 weeks. Management noted that Spring 2026 innovation underperformed expectations, delivering a weaker halo effect on core items and highlighting the need to reinvigorate product momentum.

Unit Volume and Pricing Pressures

Unit volumes fell roughly five percentage points in Q4, with a $1 price increase across e.l.f. SKUs in August 2025 contributing to sharper unit declines. The company is now testing selective price reductions, and early data from cutting Halo Glow Skin Tint from $18 to $14 show unit lifts of about 38% on Amazon and 36% overall, suggesting elasticity-driven upside.

Q4 Profitability Decline

Despite strong sales, profitability compressed in Q4 as the company leaned into spending, with adjusted EBITDA sliding to $59 million from $81 million a year ago. Adjusted net income dropped to $19 million, or $0.32 per diluted share, versus $45 million and $0.78, reflecting heavier investment rather than core margin erosion.

Rising SG&A and Marketing Investments

Adjusted SG&A climbed to 67% of net sales in Q4 from 52% a year earlier, driven largely by stepped-up brand-building and infrastructure. Marketing and digital spend reached 31% of net sales in the quarter and 24% for the full year, as management prioritized long-term share gains over near-term earnings maximization.

Tariff and Cost Headwinds

Fiscal 2026 results were burdened by an average tariff rate of about 55%, more than double the prior year, and the outlook assumes a still-elevated 35% rate going forward. Management also flagged potential $15 million to $20 million incremental cost headwinds in fiscal 2027 if oil averages around $100 per barrel, and any tariff refunds are excluded from guidance.

More Moderate FY27 Outlook and Execution Risk

Initial fiscal 2027 guidance calls for 12% to 14% net sales growth, down from 25% last year, with organic growth of 4% to 5% as Rhode’s annualization contributes the bulk of the uplift. Management acknowledged near-term cadence risk from slower Spring innovation and timing issues, with Q1 organic net sales expected to decline high single digits before new initiatives can take hold.

Higher Financing and Amortization from Deals

The Rhode acquisition, while strategically important, will also bring higher interest expense and intangible amortization in fiscal 2027. These non-cash and financing costs are expected to weigh more heavily on net income growth than on EBITDA, potentially creating a gap between operating performance and reported earnings.

Guidance and Forward-Looking Commentary

For fiscal 2027, management guided to 12% to 14% net sales growth, with Rhode’s contribution adding roughly nine percentage points and organic sales up 4% to 5% for the year after a weak Q1 and a Q2 rebound. The company expects roughly flat gross margins, adjusted EBITDA of $379 million to $385 million with about 21% margin, adjusted EPS in the low $3.30 range, and marketing spend maintained at a robust 23% to 25% of sales.

In sum, e.l.f. Beauty’s call showcased a high-growth beauty platform in transition, leaning on acquisitions, skincare, and global expansion to offset a cooling core brand and higher costs. Investors will be watching whether stepped-up innovation, pricing resets, and international rollouts can reaccelerate organic growth and translate strong strategic positioning into sustained earnings momentum.